CollabTech Manager: Tim McCann
Contact Number: 404-413-3556
Email: tmccann@gsu.edu
Current Tenants:
Cell Constructs Inc. - Cell Constructs, Inc. (CCI) is a privately
held research and development company formed in 2008 to develop and
evaluate proof-of-principle product concepts based upon the use of
adult human stem cells. These prototype products are comprised of
cultured cells, biomaterials, and cell-derived biomolecules and
biopolymers for use in tissue engineering and regenerative medicine
applications. CCI also provides contract research services to client
companies where there is an overlap of business interest. Areas of
expertise include drug delivery formulation, bioabsorbable polymers,
and surgical devices. The co-founders have decades of relevant
business and biotechnology experience both in large multi-national
corporations and small start-up ventures.
Tom Barrows, PhD.
Mr. John Daniel
Georgia Centers of Innovation - Life Sciences - Georgia's Centers of
Innovation provides unique, technology-oriented support to
businesses and entrepreneurs in the areas of aerospace,
agribusiness, energy, life sciences, logistics and advanced
manufacturing. Each of the six centers provides direct access to
university and technical college applied research, commercialization
resources, technology connections, matching grant funds, potential
investor networks and government organization. Client companies are
connected with industry-specific experts who are on the leading edge
of technology and new ideas. A common goal across all of the centers
is to cut red tape, streamline connections and seek technology
solutions to industry-led challenges; within this framework the
Centers create a pro-growth, innovative business environment for
industries critical to Georgia's expansion.
The Centers of Innovation-Life Sciences is housed on the campus of
The Medical College of Georgia in Augusta and provides statewide
strategic industry expertise while accelerating growth among
Georgia’s life sciences and biotechnology industry across the state.
Stacy Williams Shuker, PhD.
http://lifesciences.georgiainnovation.org/feature_projects/details/75
KPS Technologies - KPS Technologies produces unique cyanine dyes that absorb and fluoresce at near-
infrared wavelengths. These
molecules are useful as detection units since virtually all organic
materials including biological tissues are penetrated by NIR
radiation. Potential applications are quite varied but those of
interest are diagnostic ones including protein labeling,
immunoassays and DNA sequencing. The major market for these
compounds will be instrument manufacturers. Custom made kits are
available upon request.
Gabor Patonay, PhD.
Medical Device Development Group, LLC - The Medical Device
Development Group LLC provides medical product development for
devices in Class 1 to Class 3 using their integrated product
development method. Our services extend from product conceptualization, through prototyping and manufacturing, to order
fulfillment. We partner collaboratively with our clients to custom-
tailor the service level, so their clients pay only for services
needed to successfully launch the product. A spin off company of
MDDG is Atlanta Catheter Therapies, Inc.
Mr. Scott Hampton - President
Mr. Don White - V. President - Sales
http://med-dev-group.com/
Zygogen LLC - Founded in 1999, Zygogen is a premier provider of
zebrafish research products and services for academic and commercial
applications. We provide proprietary zebrafish embryos directly to
researchers for rapid, cost-effective, compound screening in their
own laboratories. We also offer a full complement of zebrafish-based
services, including screening assays and gene function analysis. Our
transgenic Z-TagSM zebrafish are engineered with organ and tissue-
specific fluorescence to produce robust readouts that enable high
content, in vivo screening. Individual gene targets are rapidly
interrogated using our exclusive Morphant antisense knock-down
embryos.
Nina Sawczuk - CEO
www.zygogen.com/default.asp
